کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5822174 | 1557834 | 2014 | 6 صفحه PDF | دانلود رایگان |
- KSGP O-240 strain was identified as lumpy skin disease virus.
- Commercially available KSGP O-240 vaccines should be re-characterized.
- The safety of these vaccines in cattle against LSDV should be re-evaluated.
- Two GTPV candidates were identified for use as a broad-spectrum capripox vaccine.
Lumpy skin disease is of significant economic impact for the cattle industry in Africa. The disease is currently spreading aggressively in the Near East, posing a threat of incursion to Europe and Asia. Due to cross-protection within the Capripoxvirus genus, sheep pox virus (SPPV) vaccines have been widely used for cattle against lumpy skin disease virus (LSDV). In the Middle East and the Horn of Africa these vaccines have been associated with incomplete protection and adverse reactions in cattle post-vaccination. The present study confirms that the real identity of the commonly used Kenyan sheep and goat pox vaccine virus (KSGP) O-240 is not SPPV but is actually LSDV. The low level attenuation of this virus is likely to be not sufficient for safe use in cattle, causing clinical disease in vaccinated animals. In addition, Isiolo and Kedong goat pox strains, capable of infecting sheep, goats and cattle are identified for potential use as broad-spectrum vaccine candidates against all capripox diseases.
Journal: Antiviral Research - Volume 109, September 2014, Pages 1-6